REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $309,000 | – | 43,183 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 778,800 | $935,000 | 0.18% |
Allegis Investment Advisors, LLC | 366,190 | $439,000 | 0.12% |
GENERAL AMERICAN INVESTORS CO INC | 589,768 | $708,000 | 0.07% |
Acrospire Investment Management LLC | 24,881 | $30,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 114,165 | $137,000 | 0.00% |
Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $13,000 | 0.00% |
Renaissance Technologies | 727,113 | $873,000 | 0.00% |
BALDWIN BROTHERS LLC/MA | 1,750 | $2,000 | 0.00% |
VANGUARD GROUP INC | 889,850 | $1,068,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 150 | $0 | 0.00% |